127 related articles for article (PubMed ID: 11511788)
1. Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis.
Yoon GS; Yu E
J Korean Med Sci; 2001 Aug; 16(4):433-8. PubMed ID: 11511788
[TBL] [Abstract][Full Text] [Related]
2. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies.
Ruthardt M; Orleth A; Tomassoni L; Puccetti E; Riganelli D; Alcalay M; Mannucci R; Nicoletti I; Grignani F; Fagioli M; Pelicci PG
Oncogene; 1998 Apr; 16(15):1945-53. PubMed ID: 9591778
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
5. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.
Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD
J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750
[TBL] [Abstract][Full Text] [Related]
6. PML nuclear bodies are general targets for inflammation and cell proliferation.
Terris B; Baldin V; Dubois S; Degott C; Flejou JF; Hénin D; Dejean A
Cancer Res; 1995 Apr; 55(7):1590-7. PubMed ID: 7882370
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C-associated liver carcinogenesis: role of PML nuclear bodies.
Herzer K; Gerken G; Hofmann TG
World J Gastroenterol; 2014 Sep; 20(35):12367-71. PubMed ID: 25253937
[TBL] [Abstract][Full Text] [Related]
8. Expression of promyelocytic leukemia protein increases during the differentiation of human neuroblastoma cells.
Yu E; Choi EK; Kim CJ
Virchows Arch; 2003 Mar; 442(3):278-83. PubMed ID: 12647219
[TBL] [Abstract][Full Text] [Related]
9. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
10. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
[TBL] [Abstract][Full Text] [Related]
12. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
13. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Dejean A
Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
[TBL] [Abstract][Full Text] [Related]
14. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
15. Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3.
Villamor N; Costa D; Aymerich M; Esteve J; Carrió A; Rozman M; Aguilar JL; Falini B; Montserrat E; Campo E; Colomer D
Am J Clin Pathol; 2000 Nov; 114(5):786-92. PubMed ID: 11068554
[TBL] [Abstract][Full Text] [Related]
16. Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus.
Iki S; Yokota S; Okabayashi T; Yokosawa N; Nagata K; Fujii N
Virology; 2005 Dec; 343(1):106-15. PubMed ID: 16154611
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.
Mologni L; Marchesi E; Nielsen PE; Gambacorti-Passerini C
Cancer Res; 2001 Jul; 61(14):5468-73. PubMed ID: 11454693
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice.
Herzer K; Carbow A; Sydor S; Sowa JP; Biesterfeld S; Hofmann TG; Galle PR; Gerken G; Canbay A
PLoS One; 2012; 7(9):e44474. PubMed ID: 22984515
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
[TBL] [Abstract][Full Text] [Related]
20. Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies.
Katano H; Ogawa-Goto K; Hasegawa H; Kurata T; Sata T
Virology; 2001 Aug; 286(2):446-55. PubMed ID: 11485412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
